A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3
Trial details
- Registry ID
- NCT05461105
- Drugs studied
- rencofilstat, 150mg, rencofilstat, 225 mg, rencofilstat, 75 mg
TrialRedline tracks 2 clinical trials sponsored by Hepion Pharmaceuticals, Inc.: 2 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3NCT05461105 | rencofilstat, 150mg, rencofilstat, 225 mg, rencofilstat, 75 mg | Completed | 2023-04-15Actual |
| A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver FibrosisNCT05402371 | Rencofilstat | Unknown | 2025-05Estimated |
Names as written in the registry records.